Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Spyre Therapeutics (SYRE) Q4 2019 Earnings
SYRE
24
Feb
Expected
Q1 2019
Q2 2019
Q3 2019
Q4 2019
-16.5
-11.16
-5.82
-0.48
Details
Expected EPS
-0.67
Actual EPS
-16.25
Surprise EPS
-15.58
Surprise Percent
+2,325.37%
Description
Spyre Therapeutics (SYRE) has reported earnings of -16.25 per share for Q4 2019.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login